Synta Pharmaceuticals Corp. (NASDAQ: SNTA)

Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company, has dedicated their efforts to discovering, developing, and commercializing innovative pharmaceutical products for extending and enhancing the lives of patients with severe medical conditions, including cancer and chronic inflammatory disease. The company has an exceptional chemical compound library, an integrated discovery engine, and a pipeline of small molecule drug candidates with innovative chemical structures and distinct mechanisms of action. For further information, visit the Company’s web site at www.syntapharma.com.